Wells Fargo’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.24M Sell
238,428
-119,130
-33% -$1.12M ﹤0.01% 2842
2025
Q1
$2.54M Buy
357,558
+79,866
+29% +$568K ﹤0.01% 2635
2024
Q4
$3.24M Buy
277,692
+76,872
+38% +$896K ﹤0.01% 2451
2024
Q3
$4.13M Sell
200,820
-837
-0.4% -$17.2K ﹤0.01% 2254
2024
Q2
$4.51M Sell
201,657
-14,101
-7% -$316K ﹤0.01% 2137
2024
Q1
$5.94M Buy
215,758
+13,164
+6% +$362K ﹤0.01% 1927
2023
Q4
$6.18M Sell
202,594
-24,375
-11% -$743K ﹤0.01% 1863
2023
Q3
$7.18M Buy
226,969
+39,566
+21% +$1.25M ﹤0.01% 1717
2023
Q2
$7.64M Buy
187,403
+24,003
+15% +$979K ﹤0.01% 1719
2023
Q1
$6.09M Buy
163,400
+93,314
+133% +$3.48M ﹤0.01% 1861
2022
Q4
$2.45M Sell
70,086
-13,938
-17% -$486K ﹤0.01% 2494
2022
Q3
$4.7M Buy
84,024
+9,224
+12% +$516K ﹤0.01% 1941
2022
Q2
$3.87M Sell
74,800
-24,342
-25% -$1.26M ﹤0.01% 2172
2022
Q1
$7.21M Sell
99,142
-30,021
-23% -$2.18M ﹤0.01% 2020
2021
Q4
$15.3M Buy
129,163
+700
+0.5% +$82.8K ﹤0.01% 1474
2021
Q3
$17.2M Buy
128,463
+13,899
+12% +$1.86M ﹤0.01% 1714
2021
Q2
$18.6M Sell
114,564
-11,351
-9% -$1.84M ﹤0.01% 1689
2021
Q1
$10.1M Sell
125,915
-28,846
-19% -$2.31M ﹤0.01% 2100
2020
Q4
$8.42M Buy
154,761
+88,173
+132% +$4.8M ﹤0.01% 2221
2020
Q3
$1.32M Sell
66,588
-43,787
-40% -$870K ﹤0.01% 3578
2020
Q2
$2.32M Buy
110,375
+29,648
+37% +$623K ﹤0.01% 3107
2020
Q1
$988K Buy
80,727
+18,857
+30% +$231K ﹤0.01% 3462
2019
Q4
$907K Buy
61,870
+6,684
+12% +$98K ﹤0.01% 3853
2019
Q3
$737K Buy
55,186
+2,972
+6% +$39.7K ﹤0.01% 4000
2019
Q2
$855K Buy
52,214
+5,802
+13% +$95K ﹤0.01% 3894
2019
Q1
$792K Buy
46,412
+12,560
+37% +$214K ﹤0.01% 4003
2018
Q4
$462K Sell
33,852
-28,894
-46% -$394K ﹤0.01% 4255
2018
Q3
$1.8M Sell
62,746
-8,627
-12% -$247K ﹤0.01% 3456
2018
Q2
$1.95M Sell
71,373
-7,585
-10% -$207K ﹤0.01% 3434
2018
Q1
$1.66M Buy
78,958
+44,191
+127% +$931K ﹤0.01% 3477
2017
Q4
$668K Buy
34,767
+18,050
+108% +$347K ﹤0.01% 4103
2017
Q3
$415K Sell
16,717
-13,498
-45% -$335K ﹤0.01% 4324
2017
Q2
$483K Buy
30,215
+19,270
+176% +$308K ﹤0.01% 4135
2017
Q1
$154K Buy
10,945
+7,645
+232% +$108K ﹤0.01% 4770
2016
Q4
$42K Buy
3,300
+900
+38% +$11.5K ﹤0.01% 5147
2016
Q3
$41K Hold
2,400
﹤0.01% 5118
2016
Q2
$51K Buy
+2,400
New +$51K ﹤0.01% 4981